CD34 and acute myeloid leukemia: We finally investigated the expression of uPAR variants, in particular uPAR Δ5 and uPAR Δ6, in blasts obtained from 20 AML patients and in CD34+ hematopoietic stem cells (HSCs) obtained from 3 healthy donors.